Phelimin

DB18332ExperimentalSmall molecule

Phelemin (PHE-MIP) is a methacrylic acid-based copolymer purified to bind to L-phenylalanine and L-phenylalanine-containing peptides. It is under investigation for the treatment of hyperphenylalaninemia.

Code names: PHE-MIP

What you can answer from here — as of March 06, 2025

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Phelimin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account